XML 88 R5.htm IDEA: XBRL DOCUMENT v3.20.1
CONSOLIDATED STATEMENTS OF REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS’ DEFICIT - USD ($)
$ in Thousands
Common Stock
Common stock
Common Stock
Class A common stock
Additional Paid-In Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Convertible preferred stock
Series B Preferred Stock
Series C Preferred Stock
Series D Preferred Stock
Total
Balance at the beginning of the period at Dec. 31, 2016           $ 40,189        
Balance at the beginning of the period (in shares) at Dec. 31, 2016           547,974        
Increase (Decrease) in Temporary Equity                    
Issuance of preferred stock, net of issuance costs             $ 5,315 $ 59,270    
Issuance of preferred stock, net of issuance costs (in shares)             82,032 693,500    
Balance at the end of the period at Dec. 31, 2017           $ 104,774        
Balance at the end of the period (in shares) at Dec. 31, 2017           1,323,506        
Balance at the beginning of the period at Dec. 31, 2016     $ 1,682 $ (3,126) $ (31,022)         $ (32,466)
Balance at the beginning of the period (in shares) at Dec. 31, 2016 911,777                  
Increase (Decrease) in Stockholders' Equity                    
Issuance of common stock upon exercise of stock options (in shares)                   0
Foreign currency translation adjustment, net of tax       1,764           $ 1,764
Stock-based compensation expense     769             769
Net loss         (12,723)         (12,723)
Balance at the end of the period at Dec. 31, 2017     2,451 (1,362) (43,745)         (42,656)
Balance at the end of the period (in shares) at Dec. 31, 2017 911,777                  
Balance at the end of the period at Dec. 31, 2018           $ 104,774       $ 104,774
Balance at the end of the period (in shares) at Dec. 31, 2018           1,323,506 492,192 693,500   1,323,506
Increase (Decrease) in Stockholders' Equity                    
Issuance of common stock upon exercise of stock options     9             $ 9
Issuance of common stock upon exercise of stock options (in shares) 94,818                  
Foreign currency translation adjustment, net of tax       (2,358)           (2,358)
Stock-based compensation expense     867             867
Net loss         (16,237)         (16,237)
Balance at the end of the period at Dec. 31, 2018     3,327 (3,720) (59,982)         $ (60,375)
Balance at the end of the period (in shares) at Dec. 31, 2018 1,006,595                  
Balance at the end of the period (in shares) at Mar. 31, 2019             492,192 693,500 257,000 1,580,506
Increase (Decrease) in Stockholders' Equity                    
Net loss                   $ (9,329)
Balance at the beginning of the period at Dec. 31, 2018           $ 104,774       $ 104,774
Balance at the beginning of the period (in shares) at Dec. 31, 2018           1,323,506 492,192 693,500   1,323,506
Increase (Decrease) in Temporary Equity                    
Issuance of preferred stock, net of issuance costs                 $ 37,274  
Issuance of preferred stock, net of issuance costs (in shares)                 257,000  
Conversion of Series A, B, C and D preferred stock into common stock upon initial public offering           $ (142,048)        
Conversion of Series A, B, C and D preferred stock into common stock upon initial public offering(in shares)           (1,580,506)        
Balance at the end of the period (in shares) at Dec. 31, 2019                   0
Balance at the beginning of the period at Dec. 31, 2018     3,327 (3,720) (59,982)         $ (60,375)
Balance at the beginning of the period (in shares) at Dec. 31, 2018 1,006,595                  
Increase (Decrease) in Stockholders' Equity                    
Issuance of common stock upon initial public offering at $14.00 per share for cash, net of issuance costs of $9,386 $ 1   74,614             74,615
Issuance of common stock upon initial public offering at $14.00 per share for cash, net of issuance costs of $9,386(in shares) 6,000,000                  
Conversion of Series A, B, C and D preferred stock into common stock upon initial public offering $ 2   142,046             142,048
Conversion of Series A, B, C and D preferred stock into common stock upon initial public offering(in shares) 14,582,161 3,819,732                
Issuance of common stock upon exercise of stock options     16             $ 16
Issuance of common stock upon exercise of stock options (in shares) 157,636                 157,636
Foreign currency translation adjustment, net of tax       (933)           $ (933)
Stock-based compensation expense     5,565             5,565
Net loss         (43,037)         (43,037)
Balance at the end of the period at Dec. 31, 2019 $ 3   $ 225,568 $ (4,653) $ (103,019)         $ 117,899
Balance at the end of the period (in shares) at Dec. 31, 2019 21,746,392 3,819,732